Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011390) titled 'Clinical Trial for the Evaluation of the Efficacy and Safety of MCT101C on Improvement of HbA1c in Patients with Type 2 Diabetes' on Dec. 30, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Korea University Ansan Hospital
Condition:
Endocrine, nutritional and metabolic diseases
Intervention:
Others(health functional food) : The test food(MCT101C) or the control food(Placebo) is to be taken orally twice a day, 3 capsules per dose.
Recruitmen...